A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
Public ClinicalTrials.gov record NCT03644069. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A randomized, double-blind, placebo-controlled clinical study in human leukocyte antigen (HLA)-DQ 2.5+ adults with celiac disease (CeD).
Study identification
- NCT ID
- NCT03644069
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 146 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 6, 2018 (Actual)
- Primary completion
- Sep 2019 (Estimated)
- Completion
- Sep 2019 (Estimated)
- Last update posted
- Mar 19, 2019
2018 – 2019
United States locations
- U.S. sites
- 28
- U.S. states
- 21
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Diablo Clinical Research | Walnut Creek | California | 94598 | — |
| Stamford Therapeutics Consortium | Stamford | Connecticut | 06905 | — |
| Alliance Medical Research | Lighthouse PT | Florida | 33064 | — |
| Grand Teton Research Group | Idaho Falls | Idaho | 83404 | — |
| UCMC - Center for Clinical Cancer Genetics and Global Health | Chicago | Illinois | 60637 | — |
| PMG Research of McFarland Clinic | Ames | Iowa | 50010 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Heartland Research Associates | Wichita | Kansas | 67207 | — |
| Clinical Research Institute of Michigan | Chesterfield | Michigan | 48047 | — |
| Center for Digestive Health | Troy | Michigan | 48098 | — |
| West Michigan Clinical Research Center | Wyoming | Michigan | 49519 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| AB Clinical Trials | Las Vegas | Nevada | 89119 | — |
| ActivMed Practices & Research | Portsmouth | New Hampshire | 03801 | — |
| Long Island Gastrointestinal Research Group | Great Neck | New York | 11023 | — |
| Drug Trials America | Hartsdale | New York | 10530 | — |
| Celiac Disease Center at Columbia University | New York | New York | 10032 | — |
| PMG Research of Piedmont Healthcare | Statesville | North Carolina | 28625 | — |
| PMG Research of Winston-Salem, LLC | Winston-Salem | North Carolina | 27103 | — |
| Great Lakes Gastroenterology Research | Mentor | Ohio | 44060 | — |
| Thomas Jefferson University Hospitals - Center City Campus | Philadelphia | Pennsylvania | 19107 | — |
| Ocean State Clinical Research Partners | Lincoln | Rhode Island | 02865 | — |
| Omega Medical Research | Warwick | Rhode Island | 02886 | — |
| Coastal Carolina Research | Mt. Pleasant | South Carolina | 29464 | — |
| Digestive Health Research | Hermitage | Tennessee | 37076 | — |
| Texas Digestive Disease Consultants | Southlake | Texas | 76092 | — |
| Advanced Research Institute | South Ogden | Utah | 84405 | — |
| Allegiance Research Specialists | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03644069, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 19, 2019 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03644069 live on ClinicalTrials.gov.